26 October 2023 BOLD Innovations That Matter. Translating science into meaningful therapies 9.15am (Pacific Daylight time), Spotlight Track II: Leading the Next Generation Therapies Team member attending: Dr Giuseppe Mazza, CEO [speaker] View program
12-14 May 2023 EASL – Biliary Fibrosis: Pathophysiology and translational opportunities Florence, Italy Presentation and panel discussion with Dr Giuseppe Mazza, CEO 13 May – 09:20-09:50 – 20min lecture: “The matrisome in biliary fibrosis” 13 May – 11:25-12:55 – panel discussion View program
05 October 2022 Engitix Celebrates Move to Expanded Purpose-designed Facilities in White City, West London
19 November 2021 Engitix hosts the Italian Ambassador to London
29 October 2021 Engitix Halloween Party
21 July 2021 Engitix Therapeutics celebrates 5th Anniversary
15-19 April 2020 EASL – The European Association for the Study of the Liver – International Liver Congress London, UK Team members attending: Dr Giuseppe Mazza, CEO, Dr Gino Van Heeke, CSO and Engitix scientists
4-5 February 2020 LSX World Congress London, UK Team members attending: Dr Giuseppe Mazza, CEO [panel speaker]
13-16 January 2020 Biotech Showcase / J.P. Morgan Healthcare Conference San Francisco, USA Team members attending: Dr Giuseppe Mazza, CEO, David Dally, CFO
20-21 November 2019 Jefferies 2019 London Healthcare Conference London, UK Team members attending: Dr Giuseppe Mazza, CEO, David Dally, CFO, Stephen Brindle, COO
